Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8616897 | 0.97 | MEN1 (0.50) | LMNAMEN1KMT2AHSD17B10HDAC8 | |
| SCHEMBL1525323 | 0.87 | MEN1 (0.63) | LMNAMEN1KMT2AHDAC8HDAC3 | |
| SCHEMBL15020945 | 0.86 | MEN1 (0.61) | LMNAMEN1KMT2AHDAC8HDAC3 | |
| SCHEMBL8616893 | 0.86 | MEN1 (0.50) | LMNAMEN1KMT2AHSD17B10HDAC8 | |
| SCHEMBL1525510 | 0.84 | LMNA (0.69) | LMNAMEN1KMT2AHSD17B10HDAC8 | |
| SCHEMBL1525705 | 0.84 | MEN1 (0.68) | LMNAMEN1KMT2AHDAC8HDAC3 | |
| SCHEMBL15021080 | 0.83 | LMNA (0.68) | LMNAMEN1KMT2AHSD17B10HDAC8 | |
| SCHEMBL1525416 | 0.82 | LMNA (0.65) | LMNAMEN1KMT2AHSD17B10HDAC8 | |
| SCHEMBL18744153 | 0.77 | LMNA (0.44) | LMNAMEN1KMT2AHDAC8HDAC3 | |
| SCHEMBL18744150 | 0.77 | LMNA (0.44) | LMNAMEN1KMT2AHDAC8HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2316819-B1 | Self-assembled nanostructures | XEROX CORP (US) | 2017-11-08 | — | — | EP | disclosed |
| US-8703988-B2 | Self-assembled nanostructures | XEROX CORPORATION (US) | 2014-04-22 | — | — | US | disclosed |
| US-8703988-B2 | Self-assembled nanostructures | XEROX CORPORATION (US) | 2014-04-22 | — | — | US | disclosed |
| US-20110311813-A1 | SELF-ASSEMBLED NANOSTRUCTURES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-12-22 | — | — | US | disclosed |
| US-20110311813-A1 | SELF-ASSEMBLED NANOSTRUCTURES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-12-22 | — | — | US | disclosed |
| EP-2316819-A2 | Self-assembled nanostructures | Xerox Corporation (US) | 2011-05-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110311813-A1 | SELF-ASSEMBLED NANOSTRUCTURES | ARG1, H1-3, H1-4 | LMNA 511/4885MEN1 1068/4885KMT2A 1625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.